Virtu Financial LLC Cocrystal Pharma, Inc. Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.27 - $3.6 $12,964 - $172,861	48,017 New	48,017 $14,000
Q2 2022 Aug 09, 2022	SELL	$0.38 - $0.55 $5,410 - $7,830	-14,237 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.48 - $0.71 $6,833 - $10,108	14,237 New	14,237 $8,000
Q4 2021 Feb 17, 2022	SELL	$0.65 - $1.02 $12,177 - $19,108	-18,734 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.01 - $1.25 $98,869 - $122,363	-97,891 Reduced 83.94%	18,734 $20,000
Q2 2021 Sep 17, 2021	BUY	$1.08 - $2.14 $42,447 - $84,108	39,303 Added 50.83%	116,625 $146,000
Q1 2021 May 19, 2021	BUY	$1.3 - $2.35 $55,806 - $100,880	42,928 Added 124.81%	77,322 $107,000
Q4 2020 Feb 24, 2021	SELL	$0.8 - $2.16 $45,832 - $123,746	-57,290 Reduced 62.49%	34,394 $47,000
Q3 2020 Dec 11, 2020	BUY	$0.86 - $2.36 $78,848 - $216,374	91,684 New	91,684 $85,000
Q2 2020 Aug 07, 2020	SELL	$0.7 - $1.58 $19,838 - $44,778	-28,341 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$0.39 - $2.05 $11,052 - $58,099	28,341 New	28,341 $14,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.